Bozhou is committed to building the world's traditional Chinese medicine

Time: 2017/9/27 people.com.cn

      According to the white paper on drug safety in anhui province, there were 342 drug production enterprises and 151 bozhou cities in 2016, accounting for 44.15% of the province. There are 175 companies in the province, and 141 in bozhou, accounting for 80.57 percent, accounting for 12.28 percent of the 1,148 nationwide. Bozhou city has 73 drug wholesalers, accounting for 16.40% of the total of 445 wholesale enterprises in the province. Among them, China (bozhou) Chinese medicinal materials trading center is the most listed and most traded Chinese medicine professional market in China, with annual turnover of 28 billion yuan. At present, the bozhou is seriously implement the national and provincial all policy decisions about traditional Chinese medicine industry development, to ensure that by 2020 Chinese medicine industry "ShuangQian million" development goals, to the world of traditional Chinese medicine.

Modern Chinese medicine extraction equipment.

      The system of producing raw materials of Chinese medicinal materials

      Recently, the reporter comes to bozhou city wide han Chinese medicine science and technology co., LTD in raw base, the relevant person in charge of the company Zhang Yuyao introduction, Chinese herbal medicine production process is an important part of the Chinese herbal medicine production and quality formation, is also a important link to safeguard the quality of traditional Chinese medicine (TCM). Han guang company since it was founded in 2011, to inheriting and developing traditional Chinese culture as its own duty, to scale, standardization and intensive processing Chinese medicinal materials production as a fundamental, in order to "provide users with high quality raw material of traditional Chinese medicines stable" for the purpose, put forward the concept of "Chinese green machining" as the action plan, dedicated to "let everybody eat Chinese traditional medicine".

      We have learned, in September 2015, guang han Chinese medicine science and technology set up the nation's first in bozhou "origin in raw base", using the han group independent research and development of advanced special processing equipment, production, processing and quality assurance of traditional Chinese medicine, combined with tracing sensor to realize the traceability of traditional Chinese medicine.

      After more than two years of actual operation, the current bozhou herbs in raw base has been completed in bozhou real estate herbs such as radix paeoniae alba, radix angelicae, rhizoma anemarrhenae, cortex moutan, etc. More than 10 varieties of pretreating process research, and finish the industrialized mass production, the radiation around the 19th in the town, 18 in the town, WuMa Town, tong town, the town of ocean, sand town, such as more than 20 villages and towns, annual output can reach more than 5000 tons, improve surrounding hundreds employment, driving around more than 10 varieties of planting.

      Bozhou herbs in raw base of innovation "sales" harvested patterns across all of the intermediate links, make traditional Chinese drug directly into the downstream enterprises, formed "the same price the best quality, best price on equal quality" features of the product. Predicts 2020, han Chinese medicine science and technology in order to "nearly hundred base group of joint marketing model" as the foundation, to create a centralized storage, centralized distribution, centralized sales etc various flexible marketing methods, truly from the root to the sales line management, subversion industry status quo.

      At present, there are more than 30 producing area processing bases (anhui province has bozhou and eddy Yang) to complete construction and put into production. In 2017, tasly group formally in han guang company, before the end of the year will jointly producing authentic Chinese herbal medicine in the country to establish medicinal origin early 60 home processing plants, to further improve the while fresh processing technology of Chinese medicinal materials, establish a whole category of pretreating technology system and the standard of Chinese medicinal materials and the development related to Chinese herbal medicine planting, processing and storage of all kinds of new technologies, new products, establish and improve the traditional Chinese medicine industry chain traceability system all together.

      The agglomeration effect of traditional Chinese medicine is becoming more and more prominent

      Bozhou city's grab and grab is listed as the first strategic emerging industry cluster development base of historical opportunity, the combination of multiple policies overlapping advantages, powerful driving industry gathering and development. In 2016, the base completed industrial output of 28.81 billion yuan, up 26.2%. The tax revenue was 7.9 billion yuan, up 40.2 percent. The pharmaceutical industry achieved a total of $210 million in exports and 18.8% growth, accounting for 41.2% of the total import and export volume of the whole city. From January to August this year, the total output value of pharmaceutical manufacturing in the whole city reached 20.7 billion yuan, up 26.4 percent.

      22 new industrial enterprises above designated size, total of 200, of which 167 through the GMP certification enterprises, covering agriculture, traditional Chinese medicine industry, traditional Chinese medicine (TCM) business, Chinese materia medica derivative industry and modern service industry of Chinese traditional medicine Chinese traditional medicine science and technology industrial system basic formation. In addition, 67 pharmaceutical companies have increased the production line of oral and beverage tablets, and the development of traditional Chinese medicine in the direction of deep processing; Taian tang (bozhou) pharmaceutical, treasure island pharmaceutical and other established digital extraction production line, the automatic production capacity of TCM has been greatly improved.

      Provincial food and drug supervision bureau granted for construction, the bozhou city immediately on TCM formula granule production base construction to promote work plan, organization nione pharmaceutical, jiuzhou fangyuan pharmaceutical co., shenyang hongyao tablets (bozhou) group, and other 12 companies declare and traditional Chinese medicine formula particles clinical pilot study work, at present, ShengJu five acceptance and approval. "369" plan of action to advance Chinese medicine industry, focus on building material market, the formation of sig hua tuo (bozhou) traditional Chinese medicine, taian city hall plaza, chang liters of fresh Chinese medicine city, treasured island, kyushu electric business logistics center logistics park, age six Chinese medicinal materials markets, such as medical city last year turnover of 24.3 billion yuan, or about one third of the country's.

      We will promote the construction of the traditional Chinese medicine Internet market by relying on e-commerce platforms such as drug network, drug mart, and treasure island. Implement the Chinese medicinal materials futures exchange project, catch the development trend of traditional Chinese medicine futures, explore the construction of Chinese medicinal materials commodity and futures trading market. In 2016, the planting area of Chinese medicinal materials in the whole city was 1.13 million mu, accounting for 10% of the whole country and 60% of the whole province.

      In 2016, the total of 76 pharmaceutical projects and the total investment of 30 billion yuan were planned. Among them, there were 14 projects of more than 500 million yuan, 3 global 500 enterprises and 10 top 100 enterprises in China. A number of major projects, such as changbaishan pharmaceutical, a 5.8-billion yuan investment, and the $4 billion endu modern Chinese medicine and food processing, have been signed to the ground. This year, we have signed 156 projects and total investment of 35.23 billion yuan.